![Ivan Bergstein](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ivan Bergstein
Directeur Général chez
STEMLINE THERAPEUTICS, INC.
Profil
Ivan Bergstein is the founder of Stemline Therapeutics, Inc. (2003) as President & Chief Executive Officer.
Current job is at Lirum Therapeutics, Inc. as Chairman since 2021.
Former jobs include Medical Director at Keryx Biopharmaceuticals, Inc., Medical Director at ACCESS Oncology, Inc., and Senior Biopharmaceuticals Analyst at Nitron Advisors.
Education includes an undergraduate degree from the University of Pennsylvania and a doctorate from Icahn School of Medicine at Mount Sinai.
Postes actifs de Ivan Bergstein
| Sociétés | Poste | Début |
|---|---|---|
| STEMLINE THERAPEUTICS, INC. | Directeur Général | - |
| LIRUM THERAPEUTICS, INC. | Président | 01/11/2021 |
Anciens postes connus de Ivan Bergstein
| Sociétés | Poste | Fin |
|---|---|---|
Nitron Advisors
 Nitron Advisors Investment ManagersFinance Operates investment research company | Corporate Officer/Principal | - |
| KERYX BIOPHARMACEUTICALS | Directeur Technique/Scientifique/R&D | - |
ACCESS Oncology, Inc.
 ACCESS Oncology, Inc. Pharmaceuticals: OtherHealth Technology Develops pharmaceutical drugs | Directeur Technique/Scientifique/R&D | - |
Formation de Ivan Bergstein
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
13
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
ACCESS Oncology, Inc.
ACCESS Oncology, Inc. Pharmaceuticals: OtherHealth Technology Develops pharmaceutical drugs | Health Technology |
Stemline Therapeutics, Inc.
 Stemline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel oncology therapeutics | Health Technology |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Icahn School of Medicine at Mount Sinai
 Icahn School of Medicine at Mount Sinai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nitron Advisors
Nitron Advisors Investment ManagersFinance Operates investment research company | Finance |
Lirum Therapeutics, Inc.
 Lirum Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that focuses on the treatment of debilitating diseases | Health Technology |
